India Glycols' revenue increased 13.0% YoY
  • 15 May 2026
  • India Glycols Ltd reported a 11.4% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 13.0%.
  • Its expenses for the quarter were down by 13.5% QoQ and up 10.5% YoY.
  • The net profit increased 28.6% QoQ and increased 35.7% YoY.
  • The earnings per share (EPS) of India Glycols Ltd stood at 13.64 during Q4 FY 2025-26.

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

India Glycols Ltd is a prominent company operating in the chemical industry, primarily known for its production of glycols, ethoxylates, and performance chemicals. The company is also involved in manufacturing specialty chemicals, natural gums, spirits, industrial gases, and nutraceuticals. India Glycols Ltd has an established presence in both domestic and international markets, supplying products to a diverse set of industries including automotive, pharmaceuticals, textiles, and consumer goods. As of the data provided, there were no specific recent developments mentioned for the company. Information regarding recent major developments or specific changes in their product lines or market strategies is not available.

In Q4FY26, India Glycols Ltd reported total income of ₹976.97 crores, experiencing an 11.4% decline in revenue from the previous quarter, Q3FY26, where the total income was ₹1103.14 crores. However, compared to the same quarter in the previous year, Q4FY25, the total income increased by 13.0%, when the company reported ₹864.81 crores. This indicates fluctuations in the company's quarterly revenue performance while maintaining a positive year-over-year growth. The YoY growth suggests an overall upward trend in revenues compared to the previous fiscal year, demonstrating the company's ability to generate higher income despite quarterly variations.

The company's profitability metrics reveal an upward trend with profit before tax (PBT) in Q4FY26 at ₹99.48 crores, showcasing a 13.9% increase from Q3FY26's ₹87.35 crores and a substantial 41.3% increase compared to Q4FY25's ₹70.41 crores. Profit after tax (PAT) similarly showed significant growth, with a 28.6% quarter-over-quarter increase from ₹67.57 crores in Q3FY26 to ₹86.88 crores in Q4FY26. Year-over-year, PAT increased by 35.7% from ₹64.02 crores in Q4FY25. The tax expense for Q4FY26 stood at ₹25.58 crores, reflecting an 11.0% increase QoQ and a 44.0% increase YoY. Despite the higher tax expense, the net profitability has improved, as indicated by the PAT figures over both comparative periods.

The total expenses for Q4FY26 were ₹877.49 crores, which decreased by 13.5% from ₹1014.96 crores in Q3FY26. When compared to Q4FY25, where expenses were ₹794.40 crores, there was an increase of 10.5%. This suggests an effective cost management strategy, resulting in reduced expenses quarter-over-quarter while managing resources efficiently on a yearly basis. Earnings per share (EPS) in Q4FY26 was ₹13.64, a 26.4% increase from ₹10.79 in Q3FY26. However, it showed a 34.0% decrease from ₹20.68 in Q4FY25. The decrease in EPS year-over-year despite increased profits suggests a possible increase in the number of shares outstanding or a change in the capital structure.

India Glycols Ltd announced its Q4 FY 2025-26 results on 15 May, 2026.

India Glycols Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.

Key highlights of India Glycols Ltd Q4 FY 2025-26 results include:

  • Revenue: ₹976.97 crore
  • Net Profit: ₹86.88 crore
  • EBITDA: ₹167.12 crore
  • Year-over-Year Growth: 13.0%
  • Quarter-over-Quarter Growth: -11.4%

India Glycols Ltd reported a net profit of ₹86.88 crore in Q4 FY 2025-26, reflecting a 35.7% year-over-year growth.

India Glycols Ltd posted a revenue of ₹976.97 crore in Q4 FY 2025-26.